Registro:

Referencias:

• Ruffell, B., Denardo, D.G., Affara, N.I., Coussens, L.M., Lymphocytes in cancer development: Polarization towards pro-tumor immunity (2010) Cytokine Growth Factor Rev, 21, pp. 3-10
• Schreiber, R.D., Old, L.J., Smyth, M.J., Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion (2011) Science, 331, pp. 1565-1570
• Rabinovich, G.A., Croci, D.O., Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer (2012) Immunity, 36, pp. 322-335
• Liu, F.T., Rabinovich, G.A., Galectins as modulators of tumour progression (2005) Nat Rev Cancer, 5, pp. 29-41
• Salatino, M., Rabinovich, G.A., Fine-tuning antitumor responses through the control of galectin-glycan interactions: An overview (2011) Meth Mol Biol, 677, pp. 355-374
• Thijssen, V.L., Barkan, B., Shoji, H., Aries, I.M., Mathieu, V., Deltour, L., Tumor cells secrete galectin-1 to enhance endothelial cell activity (2010) Cancer Res, 70, pp. 6216-6224
• Rotblat, B., Niv, H., Andre, S., Kaltner, H., Gabius, H.J., Kloog, Y., Galectin-1 (L11A) predicted from a computed galectin-1 farnesyl-binding pocket selectively inhibits Ras-GTP (2004) Cancer Res, 64, pp. 3112-3118
• Salatino, M., Croci, D.O., Bianco, G.A., Ilarregui, J.M., Toscano, M.A., Rabinovich, G.A., Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer (2008) Expert Opin Biol Ther, 8, pp. 45-57
• Rubinstein, N., Alvarez, M., Zwirner, N.W., Toscano, M.A., Ilarregui, J.M., Bravo, A., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: A potential mechanism of tumor-immune privilege (2004) Cancer Cell, 5, pp. 241-251
• Banh, A., Zhang, J., Cao, H., Bouley, D.M., Kwok, S., Kong, C., Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis (2011) Cancer Res, 71, pp. 4423-4431
• Kuo, P.L., Huang, M.S., Cheng, D.E., Hung, J.Y., Yang, C.J., Chou, S.H., Lung cancer-derived galectin-1 enhances tumorigenic potentiation of tumor-associated dendritic cells by expressing heparin-binding EGF-like growth factor (2012) J Biol Chem, 287, pp. 9753-9764
• Juszczynski, P., Ouyang, J., Monti, S., Rodig, S.J., Takeyama, K., Abramson, J., The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma (2007) Proc Natl Acad Sci U S A, 104, pp. 13134-13139
• Gandhi, M.K., Moll, G., Smith, C., Dua, U., Lambley, E., Ramuz, O., Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma (2007) Blood, 110, pp. 1326-1329
• Soldati, R., Berger, E., Zenclussen, A.C., Jorch, G., Lode, H.N., Salatino, M., Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments (2012) Int J Cancer, 131, pp. 1131-1141
• Le, Q.T., Shi, G., Cao, H., Nelson, D.W., Wang, Y., Chen, E.Y., Galectin-1: A link between tumor hypoxia and tumor immune privilege (2005) J Clin Oncol, 23, pp. 8932-8941
• Tang, D., Yuan, Z., Xue, X., Lu, Z., Zhang, Y., Wang, H., High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer (2012) Int J Cancer, 130, pp. 2337-2348
• Kovacs-Solyom, F., Blasko, A., Fajka-Boja, R., Katona, R.L., Vegh, L., Novak, J., Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1 (2010) Immunol Lett, 127, pp. 108-118
• Cedeno-Laurent, F., Watanabe, R., Teague, J.E., Kupper, T.S., Clark, R.A., Dimitroff, C.J., Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma (2012) Blood, 119, pp. 3534-3538
• Kreunin, P., Yoo, C., Urquidi, V., Lubman, D.M., Goodison, S., Proteomic profiling identifies breast tumor metastasis-associated factors in an isogenic model (2007) Proteomics, 7, pp. 299-312
• Xu, S.G., Yan, P.J., Shao, Z.M., Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis (2010) J Cancer Res Clin Oncol, 136, pp. 1545-1556
• Jung, E.J., Moon, H.G., Cho, B.I., Jeong, C.Y., Joo, Y.T., Lee, Y.J., Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer (2007) Int J Cancer, 120, pp. 2331-2338
• Toscano, M.A., Bianco, G.A., Ilarregui, J.M., Croci, D.O., Correale, J., Hernandez, J.D., Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death (2007) Nat Immunol, 8, pp. 825-834
• Toscano, M.A., Commodaro, A.G., Ilarregui, J.M., Bianco, G.A., Liberman, A., Serra, H.M., Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses (2006) J Immunol, 176, pp. 6323-6332
• He, J., Baum, L.G., Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration (2006) Lab Invest, 86, pp. 578-590
• Norling, L.V., Sampaio, A.L., Cooper, D., Perretti, M., Inhibitory control of endothelial galectin-1 on in vitro and in vivo lymphocyte trafficking (2008) FASEB J, 22, pp. 682-690
• Ilarregui, J.M., Croci, D.O., Bianco, G.A., Toscano, M.A., Salatino, M., Vermeulen, M.E., Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10 (2009) Nat Immunol, 10, pp. 981-991
• Cedeno-Laurent, F., Opperman, M., Barthel, S.R., Kuchroo, V.K., Dimitroff, C.J., Galectin-1 triggers an immunoregulatory signature in Th cells functionally defined by IL-10 expression (2012) J Immunol, 188, pp. 3127-3137
• Baatar, D., Olkhanud, P.B., Wells, V., Indig, F.E., Mallucci, L., Biragyn, A., Tregs utilize beta-galactoside-binding protein to transiently inhibit PI3K/p21ras activity of human CD8+ T cells to block their TCR-mediated ERK activity and proliferation (2009) Brain Behav Immun, 23, pp. 1028-1037
• Garin, M.I., Chu, C.C., Golshayan, D., Cernuda-Morollon, E., Wait, R., Lechler, R.I., Galectin-1: A key effector of regulation mediated by CD4+CD25+T cells (2007) Blood, 109, pp. 2058-2065
• Pulaski, B.A., Ostrand-Rosenberg, S., Mouse 4T1 breast tumor model (2001) Curr Prot Immunol, 20, p. 20
• Yamaguchi, T., Hirota, K., Nagahama, K., Ohkawa, K., Takahashi, T., Nomura, T., Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor (2007) Immunity, 27, pp. 145-159
• Croci, D., Salatino, M., Rubinstein, N., Cerliani, J.P., Cavallin, L.E., Howard, J.L., Disrupting galectin-1 interactions with Nglycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma (2012) J Exp Med, 209, pp. 1985-2000
• Olkhanud, P.B., Baatar, D., Bodogai, M., Hakim, F., Gress, R., Anderson, R.L., Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells (2009) Cancer Res, 69, pp. 5996-6004
• Pedroza-Gonzalez, A., Xu, K., Wu, T.C., Aspord, C., Tindle, S., Marches, F., Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation (2011) J Exp Med, 208, pp. 479-490
• Danna, E.A., Sinha, P., Gilbert, M., Clements, V.K., Pulaski, B.A., Ostrand-Rosenberg, S., Surgical removal of primary tumor reverses tumorinduced immunosuppression despite the presence of metastatic disease (2004) Cancer Res, 64, pp. 2205-2211
• Olkhanud, P.B., Damdinsuren, B., Bodogai, M., Gress, R.E., Sen, R., Wejksza, K., Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4 (+) T cells to T-regulatory cells (2011) Cancer Res, 71, pp. 3505-3515
• Chuck, M.I., Zhu, M., Shen, S., Zhang, W., The role of the LAT-PLC-gamma1 interaction in T regulatory cell function (2010) J Immunol, 184, pp. 2476-2486
• Shen, S., Chuck, M.I., Zhu, M., Fuller, D.M., Yang, C.W., Zhang, W., The importance of LAT in the activation, homeostasis, and regulatory function of T cells (2010) J Biol Chem, 285, pp. 35393-35405
• Croci, D.O., Salatino, M., Tumor immune escape mechanisms that operate during metastasis (2011) Curr Pharm Biotechnol, 12, pp. 1923-1936
• Ito, K., Ralph, S.J., Inhibiting galectin-1 reduces murine lung metastasis with increased CD4 (+) and CD8 (+) T cells and reduced cancer cell adherence (2012) Clin Exp Metastasis, 29, pp. 561-572
• Ito, K., Scott, S.A., Cutler, S., Dong, L.F., Neuzil, J., Blanchard, H., Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress (2011) Angiogenesis, 14, pp. 293-307
• Daroqui, C.M., Ilarregui, J.M., Rubinstein, N., Salatino, M., Toscano, M.A., Vazquez, P., Regulation of galectin-1 expression by transforming growth factor beta1 in metastatic mammary adenocarcinoma cells: Implications for tumor-immune escape (2007) Cancer Immunol Immunother, 56, pp. 491-499
• Gromov, P., Gromova, I., Bunkenborg, J., Cabezon, T., Moreira, J.M., Timmermans-Wielenga, V., Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast (2010) Mol Oncol, 4, pp. 65-89
• Zhang, W., Sommers, C.L., Burshtyn, D.N., Stebbins, C.C., Dejarnette, J.B., Trible, R.P., Essential role of LAT in T cell development (1999) Immunity, 10, pp. 323-332
• Sommers, C.L., Park, C.S., Lee, J., Feng, C., Fuller, C.L., Grinberg, A., A LAT mutation that inhibits T cell development yet induces lymphoproliferation (2002) Science, 296, pp. 2040-2043
• Aguado, E., Richelme, S., Nunez-Cruz, S., Miazek, A., Mura, A.M., Richelme, M., Induction of T helper type 2 immunity by a point mutation in the LAT adaptor (2002) Science, 296, pp. 2036-2040
• Koonpaew, S., Shen, S., Flowers, L., Zhang, W., LAT-mediated signaling in CD4+CD25+ regulatory T cell development (2006) J Exp Med, 203, pp. 119-129
• Chung, C.D., Patel, V.P., Moran, M., Lewis, L.A., Miceli, M.C., Galectin-1 induces partial TCR zeta-chain phosphorylation and antagonizes processive TCR signal transduction (2000) J Immunol, 165, pp. 3722-3729
• Stannard, K.A., Collins, P.M., Ito, K., Sullivan, E.M., Scott, S.A., Gabutero, E., Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model (2010) Cancer Lett, 299, pp. 95-110
• Delaine, T., Cumpstey, I., Ingrassia, L., Le Mercier, M., Okechukwu, P., Leffler, H., Galectin-inhibitory thiodigalactoside ester derivatives have antimigratory effects in cultured lung and prostate cancer cells (2008) J Med Chem, 51, pp. 8109-8114

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------